Back to Results
First PageMeta Content
T cells / Immunology / Cytokines / Cancer treatments / CD25 / Regulatory T cell / FOXP3 / Sirolimus / T helper cell / Biology / Immune system / Medicine


ORIGINAL ARTICLE Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs b-Cell Function S. Alice Long,1 Mary Rieck,1 Srinath Sanda,2 Jennifer B. Bollyky,2 Peter L. Sam
Add to Reading List

Document Date: 2012-09-26 11:57:14

Open Document

File Size: 675,21 KB

Share Result on Facebook

City

San Francisco / Seattle / None / Boston / New York / V450 / Bethesda / San Diego / L.A. / /

Company

S.A. LONG AND ASSOCIATES / Gould / Novartis / A.R. S.A. / Thomson / Bernstein / None IL / Tosoh / Long SA / ITN / Type 1 Diabetes Trial Net Research Group / NorthWest Lipid Laboratories / Ziegler AG / /

Currency

pence / GBP / USD / /

/

Event

FDA Phase / Product Recall / Product Issues / /

Facility

THERAPY IN T1D PATIENTS Research Institute / National Institute of Allergy / University of South Dakota / National Institute of Diabetes / Berrie Diabetes Center / University of California San Francisco / Science University / Schnitzer Diabetes Health Center / Columbia University Medical Center / Benaroya Research Institute / Israel Deaconess Medical Center / Columbia University / University of Washington / Chapel Hill / Oregon Health Sciences University / /

Holiday

between day / /

IndustryTerm

therapy for Wiskott-Aldrich syndrome / diabetes management / array technologies / Diabetes Care / /

MedicalCondition

autoimmune diabetes / HIV / Diabetes TrialNet / both spontaneous diabetes / graft-versus-host disease / combination diabetes / recurrent diabetes / intensive diabetes / fatigue / multiple sclerosis / Wiskott-Aldrich syndrome / back DIABETES / transient eosinophilia / Benaroya DIABETES / spontaneous and recurrent autoimmune diabetes / significant eosinophilia / I diabetes / HCV-induced vasculitis / autoimmune vasculitis / abdominal pain / Chronic inhibition / cancer / vasculitis / disease / human autoimmune diseases / diabetes.diabetesjournals.org DIABETES / hyperglycemia / transient b-cell dysfunction / Kidney Diseases / Diabetes / erythema / Allergy / tumor necrosis / diabetes mellitus / eosinophilia / /

MedicalTreatment

immunotherapy / antibody therapy / lymphocyte depletion / /

MusicGroup

Medicine / Immune / /

Organization

Harvard Medical School / University of Washington / Columbia University / Oregon Health Sciences University / Prolonged administration / 3Naomi Berrie Diabetes Center / Harold Schnitzer Diabetes Health Center / University of South Dakota / Benaroya Research Institute / 11Diabetes Center / American Diabetes Association / University of California San Francisco / San Francisco / National Institute of Allergy and Infectious Diseases / Department of Medicine / Israel Deaconess Medical Center / National Institute of Diabetes and Digestive / 10Rho Federal Systems Division / Columbia University Medical Center / 4Harold Schnitzer Diabetes Health Center / Naomi Berrie Diabetes Center / Oregon Health and Science University / Portland / /

Person

Jane H. Buckner / Levi-Schaffer F. Interleukin / Impaired Treg / Deborah Hefty / Naomi Berrie / S. Alice Long / Carla J. Greenbaum / /

Position

using Aushon Array Analyst / Governor / Representative / Porter / /

Product

trimethoprim / glucagon / Proleukin / Remington m24 / Rapamune / Septra / IL-2 / sulfamethoxazole / T1D / interleukin-2 production / Treg function / /

ProvinceOrState

Maryland / Oregon / New York / Washington / South Dakota / North Carolina / California / Massachusetts / /

RadioStation

Shapiro AM / /

Technology

antibodies / Transplantation / array technologies / http / genotype / /

URL

http /

SocialTag